CytoMed Therapeutics Sets Terms for Diminished $11M US IPO

IPO digital background


Asian biotech CytoMed Therapeutics ( GDTC ) has filed for a reduced $11 million initial public offering in the US.

CytoMed said it now plans to offer 2.4 million shares at a price between $4 and $5, which would raise about $11 million if the price were at the midpoint. Insurers would beaccording to an SEC filing.

Source link

Leave a Reply

Your email address will not be published. Required fields are marked *